Selected Start-Ups (09/2009)
In Vivo briefly describes these recently founded companies: Acetylon Pharmaceuticals, Avineuro Pharmaceuticals, Nanovis, TargAnox, TheraCell and Treventis.
You may also be interested in...
The firms unveiled positive Phase III data from their respective assets for treating the agitation seen in Alzheimer’s disease with Lundbeck’s candidate set to become first-to-market for the challenging behavioral symptom.
Recent executive changes in the industry include C-suite changes at AbbVie and Pharnext. Meanwhile, new directors were appointed at Zydus Lifesciences and FSD Pharma.
A group of EU member states has written to the European Commission saying that an exclusivity voucher scheme intended to stimulate R&D into new antimicrobials will stifle innovation by competitor companies and push up costs for national health systems.